Enovis (ENOV) Shares Outstanding (Weighted Average) (2010 - 2026)
Enovis (ENOV) reported Shares Outstanding (Weighted Average) of $57.3 million for Q2 2026, up 0.92% year-over-year from $56.8 million in Q2 2025, and little changed quarter-over-quarter from $57.1 million in Q4 2025.
Enovis (ENOV) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $57.3 million in Q2 2026.
- Shares Outstanding (Weighted Average) for Q2 2026 came in at $57.3 million, up 0.92% year-over-year; the trailing twelve-month figure through Apr 2026 was $57.3 million (up 0.92% YoY), and the FY2025 annual result was $57.1 million, up 3.23% from the prior year.
- Shares Outstanding (Weighted Average) steadied at $57.3 million in Q2 2026 per ENOV's latest filing, from $57.1 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $57.3 million in Q2 2026 and troughed at $53.9 million in Q2 2022.
- A 5-year average of $55.2 million and a median of $54.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) climbed 15.77% in 2022, then grew 0.63% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $54.1 million in 2022, then advanced by 0.79% to $54.5 million in 2023, then grew by 1.44% to $55.3 million in 2024, then increased by 3.23% to $57.1 million in 2025, then climbed by 0.43% to $57.3 million in 2026.
- Business Quant data shows ENOV's Shares Outstanding (Weighted Average) at $57.3 million in Q2 2026, $57.1 million in Q4 2025, and $57.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 57.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 57.31 Mn |
| Dec 31, 2025 | 57.07 Mn |
| Oct 3, 2025 | 57.03 Mn |
| Jul 4, 2025 | 56.96 Mn |
| Apr 4, 2025 | 56.79 Mn |
| Dec 31, 2024 | 55.28 Mn |
| Sep 27, 2024 | 55.07 Mn |
| Jun 28, 2024 | 54.86 Mn |
| Mar 29, 2024 | 54.69 Mn |
| Dec 31, 2023 | 54.49 Mn |
| Sep 29, 2023 | 54.55 Mn |
| Jun 30, 2023 | 54.51 Mn |
| Mar 31, 2023 | 54.33 Mn |
| Dec 31, 2022 | 54.07 Mn |
| Sep 30, 2022 | 54.03 Mn |
| Jul 1, 2022 | 53.97 Mn |
| Apr 1, 2022 | 53.87 Mn |
| Dec 31, 2021 | 51.14 Mn |
| Oct 1, 2021 | 50.27 Mn |
| Jul 2, 2021 | 48.90 Mn |